Publicación:
Pathway to effective treatment for common mental and substance use disorders in the World Mental Health Surveys: Perceived need for treatment

dc.contributor.authorHarris, Meredith G.
dc.contributor.authorKazdin, Alan E.
dc.contributor.authorHwang, Irving
dc.contributor.authorManoukian, Sophie M.
dc.contributor.authorSampson, Nancy A.
dc.contributor.authorStein, Dan J.
dc.contributor.authorViana, Maria Carmen
dc.contributor.authorVigo, Daniel V.
dc.contributor.authorAlonso, Jordi
dc.contributor.authorBruffaerts, Ronny
dc.contributor.authorBunting, Brendan
dc.contributor.authorAndrade, Laura Helena
dc.contributor.authorChardoul, Stephanie
dc.contributor.authorde Girolamo, Giovanni
dc.contributor.authorGureje, Oye
dc.contributor.authorHaro, Josep Maria
dc.contributor.authorKaram, Elie G.
dc.contributor.authorNavarro-Mateu, Fernando
dc.contributor.authorNishi, Daisuke
dc.contributor.authorPosada-Villa, José
dc.contributor.authorRapsey, Charlene
dc.contributor.authorStagnaro, Juan Carlos
dc.contributor.authorKovess-Masfety, Viviane
dc.contributor.authorMedina-Mora, Maria Elena
dc.contributor.authorZarkov, Zahari
dc.contributor.authorXavier, Miguel
dc.contributor.authorWoodruff, Peter
dc.contributor.authorWojtyniak, Bogdan
dc.contributor.authorVladescu, Cristian
dc.contributor.authorStagnaro, Juan Carlos
dc.contributor.authorScott, Kate M.
dc.contributor.authorKessler, Ronald C.
dc.contributor.authorZaslavsky, Alan M.
dc.contributor.authorNishi, Daisuke
dc.contributor.authorMoskalewicz, Jacek
dc.contributor.authorKiejna, Andrzej
dc.contributor.authorKhaled, Salma
dc.contributor.authorKessler, Ronald C.
dc.contributor.authorKawakami, Norito
dc.contributor.authorKaram, Georges
dc.contributor.authorTorres, Yolanda
dc.contributor.authorGureje, Oye
dc.contributor.authorten Have, Margreet
dc.contributor.authorDegenhardt, Louisa
dc.contributor.authorCaldas-de-Almeida, Jose Miguel
dc.contributor.authorBromet, Evelyn J.
dc.contributor.authorBorges, Guilherme
dc.contributor.authorBenjet, Corina
dc.contributor.authorAtwoli, Lukoye
dc.contributor.authorMcGrath, John J.
dc.contributor.authorKaram, Aimee Nasser
dc.contributor.authorde Jonge, Peter
dc.contributor.authorAltwaijri, Yasmin A.
dc.contributor.authorHu, Chi-Yi
dc.contributor.authorAguilar-Gaxiola, Sergio
dc.contributor.authorCía, Alfredo H.
dc.contributor.authorCardoso, Graça
dc.date.accessioned2026-05-01T06:26:17Z
dc.date.issued2025
dc.description.abstractBackground: Perceived need for treatment is a first step along the pathway to effective mental health treatment. Perceived need encompasses a person’s recognition that they have a problem and their belief that professional help is needed to manage the problem. These two components could have different predictors. Methods: Respondents aged 18+ years with 12-month mental disorders from 25 representative household surveys in 21 countries in the World Mental Health Survey Initiative (n = 12,508). All surveys included questions about perceived need; 16 surveys (13 countries) included additional questions about respondents’ main reason for perceived need—problem recognition or perceived inability to manage without professional help (n = 9814). Associations of three sets of predictors (disorder, socio-demographics, past treatment) with perceived need and its components were examined using Poisson regression models. Results: Across the 16 surveys with additional questions, 42.4% of respondents with a 12-month mental disorder reported perceived need for treatment. In separate multivariable models for each predictor set: (1) Most disorder types (except alcohol use disorder, specific phobia), disorder severity, and number of disorders were associated with perceived need and both of its components; (2) Sociodemographic factors tended to differentially predict either problem recognition (females, 30–59 years, disabled/unemployed) or need for professional help (females, homemakers, disabled/unemployed, public insurance); (3) Past treatment factors (type of professional, psychotherapy, helpful or unhelpful treatment) were associated with perceived need and both components, except number of past professionals differentially predicted problem recognition. In a consolidated model: employment and insurance became non-significant; type and number of past professionals seen became more important; helpful past treatment predicted greater need for professional help while unhelpful treatment predicted lower problem recognition. Problem recognition was the more important component in determining perceived need for some groups (e.g., severe disorder, people who consulted non-mental health professionals). Conclusions: Greater clinical need is a key determinant of perceived need for treatment. Findings suggest a need for strategies to address low perceived need (e.g., in males, older people, alcohol use disorders) and lower endorsement of professional treatment in some groups, and to improve patient’s treatment experiences which are important enablers of future help-seeking. © The Author(s) 2025.en_US
dc.description.sponsorshipFunding text 1: The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. ; Funding text 2: The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency. ; Funding text 3: The Polish project Epidemiology of Mental Health and Access to Care \u2013EZOP Project (PL 0256) was carried out by the Institute of Psychiatry and Neurology, Warsaw in consortium with the Department of Psychiatry, Medical University, Wroclaw, the National Institute of Public Health\u2014National Institute of Hygiene, Warsaw and in partnership with Psykiatrist Institut, Vinderen, Universitet Oslo. The project was funded by the European Economic Area Financial Mechanism and the Norwegian Financial Mechanism. EZOP project was co-financed by the Polish Ministry of Health. The second Polish survey, EZOP \u2013 2, was carried out by the Institute of Psychiatry and Neurology, Warsaw in collaboration with colleagues from the National Institute of Public Health \u2013 National Institute of Hygiene, Warsaw and was entirely funded by the Polish Ministry of Health. ; Funding text 4: The Bulgarian Epidemiological Study of common mental disorders -EPIBUL\u2014is supported by the Ministry of Health and the National Center for Public Health Protection. EPIBUL 2, conducted in 2016\u201317, is supported by the Ministry of Health and European Economic Area Grants. ; Funding text 5: The Argentina survey\u2009\u2212\u2009Estudio Argentino de Epidemiolog\u00EDa en Salud Mental (EASM)\u2009\u2212\u2009was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Naci\u00F3n)\u2009\u2212\u2009(Grant Number 2002-17270/13-5). ; Funding text 6: The Mexican National Comorbidity Survey (MNCS) is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the Pan American Health Organization (PAHO). ; Funding text 7: The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health / Fogarty International Center (R03 TW006481-01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfizer, Phenicia, Servier, UPO. ; Funding text 8: The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the World Health Organization (WHO) (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. ; Funding text 9: The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and the Portuguese Ministry of Health. ; Funding text 10: Dr. Dan J. Stein is supported by the Medical Research Council of South Africa (MRC). ; Funding text 11: The S\u00E3o Paulo Megacity Mental Health Survey is supported by the State of S\u00E3o Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. ; Funding text 12: The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. ; Funding text 13: The Psychiatric Enquiry to General Population in Southeast Spain \u2013 Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejer\u00EDa de Sanidad y Pol\u00EDtica Social) and Fundaci\u00F3n para la Formaci\u00F3n e Investigaci\u00F3n Sanitarias (FFIS) of Murcia. ; Funding text 14: The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. ; Funding text 15: The Romania WMH study projects \"Policies in Mental Health Area\" and \"National Study regarding Mental Health and Services Use\" were carried out by National School of Public Health & Health Services Management (present National School of Public Health Management & Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics, SC Cheyenne Services SRL, and Statistics Netherlands. Funding was provided by the Ministry of Public Health with supplemental support of Eli Lilly Romania SRL. ; Funding text 16: The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. ; Funding text 17: The ESEMeD surveys (Belgium; France; Germany; Italy; Netherlands; Spain) were funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region [Italy]), Fondo de Investigaci\u00F3n Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnolog\u00EDa, Spain (SAF 2000-158-CE), Generalitat de Catalunya (2017 SGR 452; 2014 SGR 748), Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. ; Funding text 18: The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013, H25-SEISHIN-IPPAN-006) from the Japan Ministry of Health, Labour and Welfare.es_PE
dc.identifier.doihttps://doi.org/10.1186/s13033-025-00666-w
dc.identifier.scopus2-s2.0-105005968819
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19452
dc.language.isoeng
dc.publisherBioMed Central Ltd
dc.relation.ispartofurn:issn:1752-4458
dc.relation.ispartofseriesInternational Journal of Mental Health Systems
dc.relation.issn1752-4458
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.subjectHealth professionalsen_US
dc.subjectMental disordersen_US
dc.subjectMental health servicesen_US
dc.subjectPerceived helpfulnessen_US
dc.subjectPerceived need for treatmenten_US
dc.subjectSubstance use disordersen_US
dc.subjectTreatment historyen_US
dc.titlePathway to effective treatment for common mental and substance use disorders in the World Mental Health Surveys: Perceived need for treatmenten_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos